Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 126 Breast Neoplasms 78 Neoplasms 48 Prostatic Neoplasms 19 Fatigue 16 Obesity 14 Colorectal Neoplasms 13 Lung Neoplasms 11 Polycystic Ovary Syndrome 10 Colonic Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Head and Neck Neoplasms 7 Weight Loss 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Multiple Myeloma 5 Lymphedema 5 Leukemia 5 Inflammation 5 Pancreatic Neoplasms 4 Overweight 4 Multiple Endocrine Neoplasia Type 1 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Insulin Resistance 4 Depression 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Stomach Neoplasms 3 Peripheral Nervous System Diseases 3

Interventions

Brentuximab Vedotin 17 fludarabine 9 Cyclophosphamide 9 dacetuzumab 6 Lenalidomide 6 Bortezomib 6 ruxolitinib 5 fludarabine phosphate 5 Rituximab 5 Melphalan 5 Dexamethasone 4 Busulfan 4 lintuzumab 3 Whole-Body Irradiation 3 Mycophenolic Acid 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Doxorubicin 3 Calcium Dobesilate 3 Azacitidine 3 vosaroxin 2 spartalizumab 2 ponatinib 2 nilotinib 2 Vincristine 2 Thiotepa 2 Tacrolimus 2 Sugars 2 Stem Cell Transplantation 2 Rifampin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hematologic Diseases × Exercise × Clear all

NCT03886909 2023-07-11

IMPROVE-BMT

Milton S. Hershey Medical Center

Phase NA Completed

Hematologic Diseases, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡